NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-061-2022-0-US-02 SYSTEMS AND METHOD FOR SYNCHRONOUS CIRCUMFERENTIAL INTRAMYOCARDIAL RESYNCHRONIZATION AND PACING US National Stage 18/859,972 Pending
NCI E-229-2014-0-US-01 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION US CON 18/938,390 Pending
NHLBI E-061-2022-0-IL-01 SYSTEMS AND METHOD FOR SYNCHRONOUS CIRCUMFERENTIAL INTRAMYOCARDIAL RESYNCHRONIZATION AND PACING IL National Stage 316835 Pending
NHLBI E-222-2022-9-US-01 Catheters and Manipulators with Articulable Ends US CIP 18/937,001 Pending
NCI E-105-2023-0-PC-01 DNA METHYLATION-BASED CANCER DIAGNOSTICS PCT PCT PCT/US2024/054179 Pending
NCI E-048-2022-0-US-02 COMPOSITIONS TARGETING GPC2 AND GPC3 AND THEIR USE FOR TREATING SOLID TUMORS US National Stage 18/861,737 Pending
NHLBI E-061-2022-0-EP-01 SYSTEMS AND METHOD FOR SYNCHRONOUS CIRCUMFERENTIAL INTRAMYOCARDIAL RESYNCHRONIZATION AND PACING EP National Stage 23729551.4 Pending
NIBIB E-118-2022-0-EP-01 MICROFLUIDIC DEVICES FOR EVALUATING FIBROSIS IN MATERIAL IMPLANTATION AND CANCER EP National Stage 23726232.4 Pending
NIDCR E-196-2021-0-EP-01 LENS ARRAY BASED IMAGING SYSTEM WITH IMPROVED FIELD OF VIEW EP National Stage 23724989.1 Pending
NIDCR E-196-2021-0-US-02 LENS ARRAY BASED IMAGING SYSTEM WITH IMPROVED FIELD OF VIEW US National Stage 18/859,972 Pending
NIBIB E-118-2022-0-US-02 MICROFLUIDIC DEVICES FOR EVALUATING FIBROSIS IN MATERIAL IMPLANTATION AND CANCER US National Stage 18/859,345 Pending
NHLBI E-036-2022-0-EP-01 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS EP National Stage 23722117.1 Pending
NINDS E-113-2022-1-US-01 RECOMBINANT POLYPEPTIDES COMPRISING SINGLE-DOMAIN ANTIBODIES TARGETING HERV-K SUBTYPE HML-2 US National Stage 18/859,027 Pending
NCATS E-042-2022-0-AU-01 SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS AU National Stage 2023241585 Pending
NCI E-112-2022-0-US-02 GENETICALLY ENGINEERED CELLS, THEIR USES, AND METHODS OF MAKING SAME US National Stage 18/858,315 Pending
NCATS E-042-2022-0-EP-01 SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS EP National Stage 23721051.3 Pending
NIAID E-073-2022-0-EP-01 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE EP National Stage 23718605.1 Pending
NIAID E-080-2022-0-EP-01 BISPECIFIC ANTIBODIES TO HIV-1 ENV AND THEIR USE EP National Stage 23718600.2 Pending
NCI E-041-2018-0-EP-01 A METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER EP DIV 24206864.1 Pending
NHLBI E-119-2022-0-IL-01 SHORT APOLIPOPROTEIN E MIMETIC PEPTIDES AND METHODS OF USE IL National Stage 316418 Pending
NEI E-015-2019-0-HK-01 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE HK CN 42024098024.3 Pending
NIAID E-297-2016-2-JP-01 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES JP DIV 2024-178707 Pending
NIDDK E-067-2022-1-EP-01 A3 ADENOSINE RECEPTOR POSITIVE ALLOSTERIC MODULATORS EP National Stage 23718513.7 Pending
NIAID E-047-2022-0-CN-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses CN National Stage 202380033468.8 Pending
NCI E-239-2017-0-CN-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS CN DIV 202411410030.X Pending
NIAID E-090-2021-0-US-02 Bispecific Antibodies To Ebola Virus Glycoprotein And Their Use US National Stage 18/855,271 Pending
NHLBI E-036-2022-0-US-02 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS US National Stage 18/854,623 Pending
NIAID E-137-2018-2-BR-01 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response BR DIV BR1220240208121 Pending
NIAID E-060-2022-0-US-02 BETA GLOBIN MIMETIC PEPTIDES AND THEIR USE US National Stage 18/854,503 Pending
NHLBI E-052-2022-0-US-02 INFUSION DEVICE FOR THE PREPARATION AND DELIVERY OF MRI PROBES US National Stage 18/854,462 Pending
NCI E-067-2017-0-JP-02 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES JP DIV 2024-174698 Pending
NHLBI E-052-2022-0-JP-01 INFUSION DEVICE FOR THE PREPARATION AND DELIVERY OF MRI PROBES JP National Stage 2024-559257 Pending
NHLBI E-036-2022-0-JP-01 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS JP National Stage 2024-559137 Pending
NCI E-225-2024-0-PC-01 COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES PCT PCT PCT/US2024/049800 Pending
NHLBI E-090-2020-1-PC-01 NK CELLS OR T CELLS EXPRESSING CHIMERIC HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND METHODS OF USE PCT PCT PCT/US2024/049658 Pending
NIAAA E-189-2021-0-EP-01 CANNABINOID RECEPTOR MODULATING COMPOUNDS EP National Stage 23719936.9 Pending
NCI E-231-2023-0-PC-01 COMPOSITIONS AND METHODS FOR PRODUCING DENDRITIC CELL-BASED VACCINES WITH ENHANCED EFFICACY PCT PCT PCT/US2024/049057 Pending
NEI E-155-2023-0-PC-01 BIOREACTOR SYSTEM PCT PCT PCT/US2024/049060 Pending
NCATS E-042-2022-0-CN-01 SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS CN National Stage 202380031329.1 Pending
NIBIB E-054-2018-0-MO-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER MO CN J/8699 Pending
NCATS E-042-2022-0-US-02 SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS US National Stage 18/851,859 Pending
NIAID E-079-2022-0-US-02 BASE-COVERED HIV-1 ENVELOPE ECTODOMAINS AND THEIR USE US National Stage 18/852,276 Pending
NIAID E-067-2016-3-US-01 METHOD OF VACCINATION WITH AN ATTENUATED RSV VACCINE FORMULATION US CON 18/898,953 Pending
NIAID E-137-2018-2-KR-01 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response KR DIV 10-2024-7032485 Pending
NHLBI E-160-2023-0-PC-01 N-Lactoyl-Phenylalanine (Lac-Phe) compound derivatives PCT PCT PCT/US2024/048617 Pending
NHLBI E-052-2022-0-IL-01 INFUSION DEVICE FOR THE PREPARATION AND DELIVERY OF MRI PROBES IL National Stage 315942 Pending
NHLBI E-052-2022-0-CA-01 INFUSION DEVICE FOR THE PREPARATION AND DELIVERY OF MRI PROBES CA National Stage 3246953 Pending
NCATS E-042-2022-0-CA-01 SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS CA National Stage 3246976 Pending
NIAID E-080-2022-0-ZA-01 BISPECIFIC ANTIBODIES TO HIV-1 ENV AND THEIR USE ZA National Stage 2024/07299 Pending
NIAID E-080-2022-0-CA-01 BISPECIFIC ANTIBODIES TO HIV-1 ENV AND THEIR USE CA National Stage 3246703 Pending